| RS387907367 |
RP1L1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 88, Retinitis pigmentosa 88 |
| RS387907368 |
RNF216
|
Health Risk |
Pathogenic |
Cerebellar ataxia-hypogonadism syndrome, Cerebellar ataxia-hypogonadism syndrome |
| RS387907369 |
RNF216
|
Health Risk |
Pathogenic |
Cerebellar ataxia-hypogonadism syndrome, Cerebellar ataxia-hypogonadism syndrome |
| RS387907370 |
RNF216
|
Health Risk |
Pathogenic |
Cerebellar ataxia-hypogonadism syndrome, Cerebellar ataxia-hypogonadism syndrome |
| RS387907371 |
FLNA
|
Health Risk |
Pathogenic |
Terminal osseous dysplasia-pigmentary defects syndrome, Heterotopia |
| RS387907372 |
FGFR2
|
Health Risk |
Pathogenic |
Acrocephalosyndactyly type I, Acrocephalosyndactyly type I |
| RS387907373 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS387907374 |
SLC40A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hemochromatosis type 4, Hemochromatosis type 4 |
| RS387907377 |
SLC40A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hemochromatosis type 4, Hemochromatosis type 4 |
| RS387907389 |
ACO2
|
Health Risk |
Pathogenic |
— |
| RS387907394 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia 1, Familial hypocalciuric hypercalcemia 1 |
| RS387907417 |
CLDN14
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 29, Autosomal recessive nonsyndromic hearing loss 29 |
| RS387907447 |
KL
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumoral calcinosis, hyperphosphatemic |
| RS387907460 |
PTH1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Chondrodysplasia Blomstrand type, Metaphyseal chondrodysplasia |
| RS387907472 |
SLC12A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Familial hypokalemia-hypomagnesemia |
| RS387907484 |
IDUA;SLC26A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hurler syndrome, Hurler syndrome |
| RS387907486 |
IDUA;SLC26A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hurler syndrome, Hurler syndrome |
| RS387907549 |
UMOD
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS387907553 |
UMOD
|
Health Risk |
Conflicting classifications of pathogenicity |
Kidney disorder, Kidney disorder |
| RS387907562 |
WNK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Pseudohypoaldosteronism type 2B, Pseudohypoaldosteronism type 2B |
| RS387907566 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, autosomal dominant |
| RS387907567 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, autosomal dominant |
| RS387907570 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, Familial Mediterranean fever |
| RS387907571 |
DNAJC13
|
Health Risk |
Conflicting classifications of pathogenicity |
Parkinson disease, late-onset |
| RS387907572 |
CYP11B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Congenital adrenal hyperplasia |
| RS387907573 |
CYP11B1
|
Health Risk |
Likely pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Glucocorticoid-remediable aldosteronism |
| RS387907575 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS387907576 |
CLCN7
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant osteopetrosis 2, Autosomal recessive osteopetrosis 4 |
| RS387907598 |
KLF1
|
Health Risk |
Pathogenic |
Congenital dyserythropoietic anemia type 4, FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6 |
| RS387907599 |
KLF1
|
Health Risk |
Pathogenic |
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6, Congenital dyserythropoietic anemia type 4 |
| RS3888565 |
ABCC1
|
Health Risk |
association |
Familial cancer of breast, Familial cancer of breast |
| RS3899076 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS3901896 |
ARNT2
|
Health Risk |
association |
Pulmonary disease, chronic obstructive |
| RS390659 |
PRPH2
|
Health Risk |
Likely pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS3917215 |
TGFB3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS3917254 |
IL1R1
|
Health Risk |
association |
Ascending aortic dissection, Ascending aortic dissection |
| RS3917296 |
IL1R1
|
Health Risk |
association |
Ascending aortic dissection, Ascending aortic dissection |
| RS3918021 |
CSF3R
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive severe congenital neutropenia due to CSF3R deficiency, Hereditary neutrophilia |
| RS3918289 |
DPYD
|
Health Risk |
Conflicting classifications of pathogenicity |
Dihydropyrimidine dehydrogenase deficiency, Inborn genetic diseases |
| RS3918290 |
DPYD
|
Health Risk |
Pathogenic/Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Fluorouracil response |
| RS3918389 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac arrhythmia, Cardiac arrhythmia |
| RS3950029 |
CCDC88C
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, CCDC88C-related disorder |
| RS3970555 |
PRODH
|
Health Risk |
Conflicting classifications of pathogenicity |
Proline dehydrogenase deficiency, Schizophrenia 4 |
| RS3970559 |
PRODH
|
Health Risk |
Conflicting classifications of pathogenicity |
Proline dehydrogenase deficiency, Schizophrenia 4 |
| RS3974499 |
SLC9B1
|
Health Risk |
Pathogenic |
Usher syndrome, Usher syndrome |
| RS397507168 |
HPS3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome |
| RS397507169 |
HPS5
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 5, Hermansky-Pudlak syndrome 5 |
| RS397507170 |
BTD
|
Health Risk |
Pathogenic/Likely pathogenic |
Biotinidase deficiency, Colon adenocarcinoma |
| RS397507171 |
BTD
|
Health Risk |
Conflicting classifications of pathogenicity |
Biotinidase deficiency, Biotinidase deficiency |
| RS397507173 |
BTD
|
Health Risk |
Conflicting classifications of pathogenicity |
Biotinidase deficiency, Biotinidase deficiency |
| RS397507174 |
BTD
|
Health Risk |
Pathogenic/Likely pathogenic |
Biotinidase deficiency, Biotinidase deficiency |
| RS397507175 |
BTD
|
Health Risk |
Pathogenic/Likely pathogenic |
Biotinidase deficiency, Biotinidase deficiency |
| RS397507176 |
BTD
|
Health Risk |
Conflicting classifications of pathogenicity |
Biotinidase deficiency, Inborn genetic diseases |
| RS397507177 |
RAD50
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Nijmegen breakage syndrome-like disorder |
| RS397507178 |
RAD50
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Nijmegen breakage syndrome-like disorder |
| RS397507179 |
RAD50
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Nijmegen breakage syndrome-like disorder |
| RS397507180 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507181 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507182 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507183 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507184 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS397507185 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS397507186 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS397507187 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS397507188 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS397507189 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS397507190 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS397507191 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS397507192 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507193 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507194 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507195 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507198 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507199 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS397507200 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507201 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS397507202 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS397507203 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS397507205 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507206 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507207 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507208 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507210 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507211 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS397507212 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS397507213 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS397507215 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507216 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507217 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507218 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507219 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507220 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507221 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507222 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507223 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS397507224 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507225 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS397507226 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS397507228 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS397507229 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |